Byfavo
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Byfavo, covering 2020-07-02 to 2026-08-26. Get the full timeline:
Most recent: EMA Authorised: Byfavo (remimazolam besilate) — Paion Pharma GmbH
7 regulatory and trial events tracked for Byfavo, covering 2020-07-02 to 2026-08-26. Get the full timeline:
Most recent: EMA Authorised: Byfavo (remimazolam besilate) — Paion Pharma GmbH